The Colloid Crystalloid Question • Is one of the oldest. • Basic yet fundamental question. • The first intervention given. • To every patient. • Often several litres. A volume expander is a type of intravenous therapy that has the function of providing volume There are two main types of volume expanders: crystalloids and colloids. Crystalloids are aqueous solutions of mineral salts or other water- soluble. Colloids and crystalloids are types of fluids that are used for fluid replacement, often intravenously (via a tube straight into the blood).
|Published (Last):||9 November 2004|
|PDF File Size:||8.87 Mb|
|ePub File Size:||13.6 Mb|
|Price:||Free* [*Free Regsitration Required]|
To assess the effect of using crista,loidi versus crystalloids in critically ill people requiring fluid volume replacement on mortalityneed for blood transfusion or renal replacement therapy RRTand adverse events specifically: Very low-certainty evidence means we are uncertain whether either fluid affected adverse events: For the most updated list of ABA Keywords and definitions go to https: Dextrans versus crystalloids We found moderate-certainty evidence that there is probably little or no difference between using dextrans or crystalloids in mortality at: We cristalloici uncertain whether dextrans or crystalloids reduce the need for blood transfusion, as we found little or no difference in blood transfusions RR 0.
We found little or no difference in allergic reactions RR 6. Since the lost blood was replaced with a suitable fluid, the now diluted blood flows more easily, even in the small vessels.
With enough blood loss, ultimately red blood cell levels drop too low for adequate tissue oxygenation, even if volume expanders maintain circulatory volume. We searched the medical literature and identified 69 relevant studies with 30, critically ill participants who were given fluid replacement in hospital or in an emergency out-of-hospital setting.
Crystalloid or colloid for goal-directed fluid therapy in colorectal surgery.
Gelatins versus crystalloids We found low-certainty collokdi that there may be little or no difference between gelatins or crystalloids in mortality: We found moderate-certainty evidence that starches probably slightly increase the need for blood transfusion RR 1. We compared a colloid suspended in any crystalloid solution versus a crystalloid isotonic or hypertonic.
The primary outcome measure was the incidence of gastrointestinal GI morbidity on postoperative day 5. We compared four types of colloid i.
Crystalloids exert a significant hydrostatic effect on capillaries that may lead to extracellular fluid accumulation. However in fristalloidi circumstances, hyperbaric oxygen therapy colloifi maintain adequate tissue oxygenation even if red blood cell levels are below normal life-sustaining levels. Physiological dissociation is approximately 1. A patient at rest uses only 25 percent of the oxygen available in their blood.
There are two main types of volume expanders: We found moderate-certainty evidence that using colloids starches; dextrans; or albumin or FFP compared to crystalloids for fluid replacement probably makes little or no difference to the number of critically ill people who die within 30 or 90 days, or by the end of study follow-up.
Lactated Ringer’sSodium bicarbonate. Starches probably increase the need for blood transfusion and renal replacement therapy slightly. Are particular types of colloid solution safer for replacing blood fluids than others? This page was last edited on 4 Novemberat Peripheral venous catheter Peripherally inserted central catheter Seldinger technique Central venous catheter.
For some outcomes, we had very few studies, which reduced our confidence in the evidence. Conclusions Using colloids starches; dextrans; or albumin or FFP compared to crystalloids for fluid replacement probably makes little or no difference to the number of critically ill people who die. We found moderate-certainty evidence that there is probably little or no difference between using starches or crystalloids in mortality at: However, it is now known that rapid infusion of NS can cause metabolic acidosis.
Secondary outcome measures included the incidence of postoperative complications, hospital length of stay, and the effect of trial fluids on coagulation and inflammation.
Crystalloid or colloid: does it matter?
Intravenous sugar solutionssuch as with glucose also called dextrosehave the advantage of providing some energy, and may thereby provide the entire or part of the energy component of parenteral nutrition. Ten studies were in out-of-hospital settings.
Certainty of evidence may improve with inclusion of three ongoing studies and seven studies awaiting classification, in future updates. The body detects the lower hemoglobin level, and compensatory mechanisms start up.
All articles with dead external links Articles with dead external links from May Wikipedia articles in need of updating from November All Wikipedia articles in need of updating. When blood is lost, the greatest immediate need is to stop further blood loss. Critically ill people may lose large amounts of blood because of trauma or burnsor have serious conditions or infections e. Study characteristics The evidence is current to February There is also a risk of hemodilution, which may occur with crystalloid administration.
The heart pumps more blood with each beat. Using starches, dextrans, albumin or FFP moderate-certainty evidenceor gelatins low-certainty evidenceversus crystalloids probably makes little or no difference to mortality.
Participants had traumaburns, or medical conditions such as sepsis. Colloid or crystalloid solutions may be used for this purpose.
Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: Some study authors did not report study methods clearly and many did not register their studies before they started, so we could not be certain whether the study outcomes were decided before or after they saw the results.
The Cochrane Database of Systematic Reviews. Similarly, we are uncertain if colloids or crystalloids increase the number of adverse events.
Colloids or crystalloids for fluid replacement in critically people
Theoretical advantages of using hydroxyethyl starch HES for cristalloiid therapy include a reduction in the total volume of fluid required, resulting in less tissue oedema. Crystalloids and colloids are the primary options for intravenous fluid resuscitation. Evidence for blood transfusions for dextrans, and albumin or FFP, is uncertain.